North America’s medical devices industry saw a drop of 32.99% in deal activity during October 2021, when compared with the last 12-month average, led by Boston Scientific’s $1.75bn acquisition of Baylis MedicalInc, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 65 medical devices industry deals worth $4.7bn were announced for the region in October 2021, against the 12-month average of 97 deals.
Of all the deal types, venture financing saw most activity in October 2021 with 46 transactions, representing a 70.8% share for the region.
In second place was M&A with 16 deals, followed by private equity deals with three transactions, respectively capturing a 24.6% and 4.6% share of the overall deal activity for the month.
In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $2.72bn, while venture financing and private equity deals totalled $1.92bn and $20m, respectively.
North America medical devices industry deals in October 2021: Top deals
The top five medical devices deals accounted for 70.3% of the overall value during October 2021.
The combined value of the top five medical devices deals stood at $3.27bn, against the overall value of $4.7bn recorded for the month.
The top five medical devices industry deals of October 2021 tracked by GlobalData were:
1) Boston Scientific $1.75bn acquisition deal with Baylis MedicalInc
2) The $600m venture financing of Hinge Health by Alkeon Capital,Coatue Management,Tiger Global and Whale Rock Capital Management
3) 3D Systems $400m acquisition deal with Volumetric
4) The $304m venture financing of Medable by Blackstone,GSR Ventures,Sapphire Ventures,Tiger Global Management and Western Technology Investment
5) Integer $220m acquisition deal with Oscor
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.